According to the migration and invasion tests, our data also revealed a similar conclusion on the potential metastasis-promoting effect of RBP4 in GBM, highlighting that RBP4 may become new therapeutic targets for both tumor growth and metastasis. This evidence concerns the gene RBP4 and glioblastoma.